These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 25115341

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New approach to cancer therapy: heparin binding-epidermal growth factor-like growth factor as a novel targeting molecule.
    Miyamoto S, Yagi H, Yotsumoto F, Horiuchi S, Yoshizato T, Kawarabayashi T, Kuroki M, Mekada E.
    Anticancer Res; 2007; 27(6A):3713-21. PubMed ID: 17970033
    [Abstract] [Full Text] [Related]

  • 9. Effects of CRM197, a specific inhibitor of HB-EGF, in oral cancer.
    Dateoka S, Ohnishi Y, Kakudo K.
    Med Mol Morphol; 2012 Jun; 45(2):91-7. PubMed ID: 22718294
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A possible clinical adaptation of CRM197 in combination with conventional chemotherapeutic agents for ovarian cancer.
    Tsujioka H, Fukami T, Yotsumoto F, Ueda T, Hikita S, Takahashi Y, Kondo H, Kuroki M, Miyamoto S.
    Anticancer Res; 2011 Jul; 31(7):2461-5. PubMed ID: 21873160
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer.
    Yagi H, Yotsumoto F, Sonoda K, Kuroki M, Mekada E, Miyamoto S.
    Int J Cancer; 2009 Mar 15; 124(6):1429-39. PubMed ID: 19048624
    [Abstract] [Full Text] [Related]

  • 15. NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.
    Bratasz A, Selvendiran K, Wasowicz T, Bobko A, Khramtsov VV, Ignarro LJ, Kuppusamy P.
    J Transl Med; 2008 Feb 26; 6():9. PubMed ID: 18302761
    [Abstract] [Full Text] [Related]

  • 16. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ, Yu C, Yang Z, He JL, Chen WJ, Yin J, Li WM, Liu HT, Wang YX.
    Mol Med Rep; 2011 Feb 26; 4(5):985-92. PubMed ID: 21687949
    [Abstract] [Full Text] [Related]

  • 17. The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers-Preclinical In Vivo Evaluation in Xenograft Tumor Models.
    Mueller T, Pfankuchen DB, Wantoch von Rekowski K, Schlesinger M, Reipsch F, Bendas G.
    Molecules; 2017 May 03; 22(5):. PubMed ID: 28467373
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J, Shi HR, Ren F, Wang JL, Wu QH, Li X, Zhang RT.
    BMC Cancer; 2017 Dec 14; 17(1):851. PubMed ID: 29241458
    [Abstract] [Full Text] [Related]

  • 19. HB-EGF Is a Promising Therapeutic Target for Lung Cancer with Secondary Mutation of EGFRT790M.
    Yotsumoto F, Fukagawa S, Miyata K, Nam SO, Katsuda T, Miyahara D, Odawara T, Manabe S, Ishikawa T, Yasunaga S, Miyamoto S.
    Anticancer Res; 2017 Jul 14; 37(7):3825-3831. PubMed ID: 28668882
    [Abstract] [Full Text] [Related]

  • 20. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H, Wei W, Sun Y, Gao J, Wang Q, Zheng J.
    DNA Cell Biol; 2015 Jan 14; 34(1):55-62. PubMed ID: 25211326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.